BP000027-GD1: Recombinant Human VEGF165 (aa 27-191) Protein
Source: HEK 293 cell-derived.
The VEGF activity is measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 1-5 ng/ml.
Endotoxin: < 1.0 EU per ug of the protein by the LAL method.
Purity: > 95% by SDS-PAGE under reducing conditions.BP000027-C083: Recombinant Human Vascular Endothelial Growth Factor Isoform 165 (VEGF165) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000179-C029: Recombinant Human Epidermal Growth Factor (EGF) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000179-CYT-217: Recombinant Human Epidermal Growth Factor (EGF) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependant proliferation of murine BALB/c 3T3 cells (measured by 3H-thymidine uptake) is < 0.1 ug/ml corresponding to a specific activity of 1 x 10,000,000 Units/mg.
Purity: > 98% by SDS-PAGE and SEC-HPLC.BP000179-CYT-326: Recombinant Mouse Epidermal Growth Factor (EGF) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependant proliferation of murine BALB/c 3T3 cells (measured by 3H-thymidine uptake) is < 0.1 ug/ml corresponding to a specific activity of 10 MUnits/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.- BP000179-CYT-332: Recombinant Human Epidermal Growth Factor (EGF) Protein, Pichia
Source: Pichia Pastoris-derived.
The ED50, calculated by the dose-dependant proliferation of murine BALB/c 3T3 cells (measured by 3H-thymidine uptake) is < 0.1 ug/ml corresponding to a specific activity of 10 MUnits/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000179-CYT-466: Recombinant Human Epidermal Growth Factor (EGF) Protein (Leu-21)
Source: E. coli-derived.
The ED50, calculated by the dose-dependant proliferation of MDCK cells is < 10 ug/ml concentration corresponding to a Specific Activity of 100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000256-CYT-338: Recombinant Human Endocrine Gland VEGF
Source: E. coli-derived.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000027-CYT-200: Recombinant Human VEGF (121 a.a.) Protein, Sf9
Source: Sf9, Insect Cells-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 2-5 ug/ml corresponding to a Specific Activity of 200,000-500,000 IU/mg.
Purity: >90% by SDS-PAGE and RP-HPLC.BP000027-CYT-225: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, HEK
Source: HEK 293 (Human Embryonic Kidney cell line)-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1-6 ug/ml corresponding to a Specific Activity of 166,667-1,000,000 IU/mg.
Purity: > 95% by SDS-PAGE.